Sign in Subscribe
Cancer research

Non-Invasive Prediction of EGFR Gene Mutations in NSCLC Using Multi-Parameter CT Perfusion Imaging

Strategic Insights

— 1 min read

Researchers at Nanchang University have made a significant breakthrough in the diagnosis of non-small cell lung cancer (NSCLC) by developing a non-invasive method to predict epidermal growth factor receptor (EGFR) gene mutations. This method uses multi-parameter CT perfusion imaging (CTPI) to analyze blood volume, transit time, and perfusion surface in NSCLC patients. The study included 86 patients with confirmed NSCLC diagnosis, who underwent CTPI within a week before biopsy, and EGFR gene detection after biopsy. The results showed that blood volume, transit time, and perfusion surface were independent predictors of EGFR mutation in NSCLC patients. A combined CTPI parameter model (BV + TTP + PS) demonstrated the highest predictive performance, outperforming any single parameter in clinical auxiliary diagnosis.

Key Takeaways:

  • The study included 86 patients with confirmed NSCLC diagnosis, 45 women and 41 men, divided into EGFR mutation and wild-type groups.
  • The results showed significant differences in blood volume between the two groups (5.56 ± 1.51 vs. 3.04 ± 1.07, p < 0.05).
  • Blood volume (BV), transit time (TTP), and perfusion surface (PS) were identified as independent predictors of EGFR mutation in NSCLC patients.
  • The combined CTPI parameter model (BV + TTP + PS) had the highest predictive performance and could be more reliable than any single parameter in clinical auxiliary diagnosis.
  • The study's conclusion emphasizes the potential of non-invasive CTPI to aid in the diagnosis of EGFR gene mutations in NSCLC patients.

Statistics:

  • 86 patients were included in the study, including 45 women and 41 men, with 47 cases in the mutation group and 39 cases in the wild-type group.
  • The mean blood volume in the mutation group was 5.56 ± 1.51, while in the wild-type group it was 3.04 ± 1.07 (p < 0.05).
  • The combined CTPI parameter model (BV + TTP + PS) had an area under the curve (AUC) of 0.85 in predicting EGFR mutation.

Sources:

  • Non-invasive prediction of EGFR gene mutations in non-small cell lung cancer by multi-parameter CT perfusion imaging. Frontiers in Medicine, 2025,12.
  • Nanchang University Researchers Release New Data on Non-Small Cell Lung Cancer (Non-invasive prediction of EGFR gene mutations in non-small cell lung cancer by multi-parameter CT perfusion imaging). Cancer Weekly. October 21, 2025; p 842.

Read more